Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia
This study has been completed.
Study NCT00377598   Information provided by Takeda Global Research & Development Center, Inc.

First Received on September 14, 2006.   Last Updated on January 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neuralgia, Postherpetic
Additional conditions recognized in this trial
Neuralgia
More general conditions related to this trial
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pain
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
TAK-583
Placebo
Sponsors listed in this trial
Takeda Global Research & Development Center, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services